Jeffrey Allen Bailey
CIK 1500210 · Chief Executive Officer · last filed 2026-06-08
Jeffrey Allen Bailey is a Chief Executive Officer who has filed 41 SEC Form 4 insider transactions across 9 companies since 2010. The most recent filing, for AUPH, was dated Jun 8, 2026. Across all open-market trades the lifetime net is +$40.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $23.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$23.93M
9
41
$40.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Director | 22,775 | $14.96 | $340.7K | -$38.4K | 6 | 2026-06-08 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | 1,788 | $2.11 | $3.8K | $38.6K | 8 | 2022-06-17 |
| THW | Director | 980 | $13.36 | $13.1K | $10.1K | 2 | 2021-04-08 |
| THQ | Director | 570 | $19.00 | $10.8K | $10.1K | 1 | 2020-09-23 |
| HQL | Director | 580 | $19.37 | $11.2K | $10.0K | 1 | 2020-09-23 |
| HQH | Director | 490 | $21.84 | $10.7K | $10.0K | 1 | 2020-09-23 |
| LANDAUER INC (LDR) Delisted | Director | 0 | — | — | $0 | 4 | 2017-10-19 |
| LNTH | CEO and President | 229,407 | $102.64 | $23.55M | $0 | 4 | 2015-09-03 |
| KG | Chief Commercial Officer | 0 | $8.69 | $0 | $0 | 2 | 2011-02-02 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2025-11-24 | AUPH | Tax (F) | −2,716 | -$42.6K | EDGAR |
| 2025-05-16 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2024-11-25 | AUPH | Grant (A) | +12,135 | $0 | EDGAR |
| 2024-11-12 | AUPH | Mixed | +13,356 | -$38.4K | EDGAR |
| 2023-08-21 | AUPH | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-22 | — | Mixed | −105,133 | $0 | |
| 2022-03-11 | — | Exer (M) | +5,333 | $0 | |
| 2022-01-31 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.